{"gene":"CD2","run_date":"2026-06-09T22:57:17","timeline":{"discoveries":[{"year":1987,"finding":"CD2 (T lymphocyte glycoprotein) binds the cell surface ligand LFA-3 (CD58) with high affinity, mediating adhesion of lymphoid cells.","method":"Purified CD2 inhibition of rosetting; cell adhesion assays with purified LFA-3","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct binding assay with purified proteins, replicated across multiple labs (PMIDs 2951597, 3102975, 3313052)","pmids":["2951597","3102975"],"is_preprint":false},{"year":1987,"finding":"LFA-3 (the ligand for CD2) is a phospholipid-linked (GPI-anchored) membrane protein whose extracellular domain shares significant homology with CD2, placing both in the immunoglobulin superfamily.","method":"cDNA cloning and transient expression in mouse cells; sequence analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — cDNA cloning with functional expression, widely replicated","pmids":["3313052"],"is_preprint":false},{"year":1987,"finding":"Binding of the natural CD2 ligand (T11TS/LFA-3) to CD2 on resting T cells induces reactivity to mitogenic anti-CD2 antibody stimuli, establishing CD2-ligand interaction as providing one signal required for alternative-pathway T cell activation.","method":"T cell stimulation assays with natural cell-surface ligand and monoclonal antibodies","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional cell stimulation assays with natural ligand, replicated across labs","pmids":["3102975"],"is_preprint":false},{"year":1987,"finding":"Mutational analysis mapped the LFA-3 binding site of CD2 to the first extracellular domain, corresponding to immunoglobulin variable region hypervariable sequences; activating anti-CD2 antibodies bind overlapping epitopes in regions 1 and 3, supporting the model that they mimic LFA-3 binding.","method":"Systematic mutagenesis of CD2 followed by antibody binding and LFA-3 binding assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct mutagenesis with functional binding readout, single lab with comprehensive mapping","pmids":["2444890"],"is_preprint":false},{"year":1988,"finding":"CD2-mediated T cell activation requires phosphoinositide turnover that is linked to the CD3-Ti complex; CD3-Ti-negative Jurkat mutants cannot be activated through either CD3 or CD2 pathways, and this is rescued by TCR reconstitution, demonstrating interdependence of the two pathways.","method":"Jurkat mutant cell lines (CD3-Ti-negative); phosphoinositide turnover assays; Ca2+ mobilization; IL-2 gene induction; DNA transfection rescue","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined biochemical readouts and rescue experiment, multiple orthogonal endpoints","pmids":["2901344"],"is_preprint":false},{"year":1989,"finding":"The CD2 extracellular adhesion domain (LFA-3 binding) is functionally separable from its cytoplasmic signal transduction domain; CD2 mutants lacking functional cytoplasmic domain still enhance antigen-specific T cell responses by up to 400% when LFA-3 is present on the same APC, demonstrating that adhesion per se contributes to T cell activation.","method":"Transfection of CD2 cytoplasmic-domain truncation mutants into antigen-specific T cell hybridoma; antigen-specific proliferation assays with LFA-3-expressing APCs","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Moderate — domain deletion mutagenesis with functional antigen-specific readout, clean experimental design","pmids":["2566919"],"is_preprint":false},{"year":1990,"finding":"CD2 is physically associated with CD45 (a tyrosine phosphatase) on the surface of human T lymphocytes, providing a molecular basis for the co-mitogenic effect of anti-CD45 and anti-CD2 antibodies.","method":"Chemical crosslinking followed by co-immunoprecipitation","journal":"Nature","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — single crosslinking/co-IP study, single lab, no functional dissection of the complex","pmids":["1970422"],"is_preprint":false},{"year":1991,"finding":"Lateral mobility of GPI-anchored LFA-3 on supported lipid bilayers enhances CD2-mediated T cell adhesion strength by facilitating receptor accumulation and bond formation in the contact zone; mobile GPI-LFA-3 strengthens adhesion faster than immobile transmembrane-LFA-3 at low ligand densities.","method":"Reconstituted planar lipid bilayers with two LFA-3 isoforms; static and laminar-flow cell adhesion assays; fluorescence recovery after photobleaching (FRAP)","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted bilayer system with two receptor isoforms, multiple quantitative assays, clean experimental design","pmids":["1717480"],"is_preprint":false},{"year":1991,"finding":"CD2 adhesion function is constitutively active in non-activated T cells and is not detectably modulated by TCR stimulation, protein kinase C activation, or cAMP; in contrast, LFA-1 adhesion is minimal at rest and upregulated by TCR signaling, demonstrating complementary roles of CD2 and LFA-1 in initiating vs. sustaining cell-cell contact.","method":"Cell adhesion assays; pharmacological modulation (PKC activators, cAMP); flow cytometry","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional adhesion assays with pharmacological dissection, single lab","pmids":["1672642"],"is_preprint":false},{"year":1992,"finding":"CD2-mediated signal transduction in T lymphocytes requires the CD3 zeta cytoplasmic domain; expression of a CD8α/CD3ζ chimeric receptor in TCR-negative Jurkat cells restored Ca2+ mobilization, protein tyrosine kinase activation, and IL-2 secretion upon CD2 stimulation, demonstrating that CD3ζ is a necessary and sufficient TCR subunit for coupling CD2 to signaling.","method":"CD8α/CD3ζ chimeric receptor transfection into TCR-negative Jurkat; Ca2+ mobilization; protein tyrosine kinase assay; IL-2 secretion","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 / Strong — chimeric receptor reconstitution with multiple signaling readouts, mechanistically definitive","pmids":["1351920"],"is_preprint":false},{"year":1992,"finding":"On NK cells, CD16 (FcγRIII) is functionally equivalent to the TCR for coupling CD2 to signaling; transfecting a transmembrane CD16 into TCR-negative Jurkat cells (which express endogenous CD3ζ) restores CD2 signaling; CD2 signaling further requires a wild-type CD3ζ subunit, establishing CD3ζ as the essential downstream effector of CD2-triggered signaling in both T and NK cells.","method":"CD16 cDNA transfection into TCR-negative Jurkat; wild-type vs. truncated CD3ζ T-T hybridomas; Ca2+ mobilization; IL-2 production","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with chimeric/mutant receptors, multiple cell lines, mechanistically rigorous","pmids":["1346934"],"is_preprint":false},{"year":1992,"finding":"CD48 is the counter-receptor for mouse CD2; identified by generating a CD2-Ig fusion protein to screen for binding partners on T cell lines; confirmed by protein microsequencing, anti-CD48 antibody blocking, and soluble CD48 inhibition; anti-CD48 antibody inhibited PHA responses and augmented anti-CD3 responses of splenic T cells.","method":"Chimeric mCD2-IgG1 fusion protein; mAb screening; protein microsequencing; soluble recombinant CD48 blocking assay; T cell proliferation assays","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical identification with multiple orthogonal methods including microsequencing and functional blocking","pmids":["1383383"],"is_preprint":false},{"year":1992,"finding":"TCR-CD3 signaling rapidly increases CD2 avidity for CD58 (LFA-3); the carboxyl-terminal asparagine of the CD2 cytoplasmic domain is essential for this avidity regulation but not for CD2-mediated signaling; cell lines incapable of CD2 avidity regulation show marked deficiency in antigen-specific T cell responses.","method":"CD2 cytoplasmic domain point mutants transfected into T cell lines; CD58-binding avidity assay; antigen-specific proliferation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis of cytoplasmic domain with functional avidity and antigen-response readouts, clean domain dissection","pmids":["1353888"],"is_preprint":false},{"year":1992,"finding":"N-glycosylation at Asn65 in the CD2 extracellular domain is essential for CD2-CD58 binding; deglycosylated CD2 or Asn65→Gln65 mutant CD2 fails to bind CD58 or conformational anti-CD2 antibodies, indicating N-glycans stabilize the adhesion domain structure.","method":"Enzymatic deglycosylation; site-directed mutagenesis (Asn65→Gln); CD58-binding assays; electrospray ionization mass spectrometry characterization of glycoforms","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis plus deglycosylation with direct binding readout, mass spectrometry characterization","pmids":["1385399"],"is_preprint":false},{"year":1993,"finding":"The CD2 cytoplasmic domain contains two structurally and functionally separable regions: one required for signal transduction (IL-2 production) and a distinct COOH-terminal 21-aa region required for TCR-induced avidity regulation for CD58; regulated avidity and signaling each independently contribute to optimal antigen-specific T cell responses.","method":"Series of CD2 cytoplasmic domain deletion/point mutants stably transfected in antigen-specific T cell hybridoma; IL-2 production assays; CD58-avidity assays","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic mutagenesis with multiple functional readouts, clean domain mapping","pmids":["7901319"],"is_preprint":false},{"year":1993,"finding":"TCR-initiated upregulation of CD2 avidity for CD58 requires both protein tyrosine kinases and protein kinase C activity; cAMP also upregulates CD2 avidity independently of PKC and PTK; all three stimuli require the COOH-terminal asparagine of CD2 cytoplasmic domain as a common structural element, distinguishing this regulatory mechanism from LFA-1 and CD8 avidity regulation.","method":"Pharmacological inhibitors of PTK and PKC; cAMP elevation; CD2 point mutants; rosetting and CD58-binding avidity assays in transfected T cell hybridomas","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological dissection combined with mutagenesis, single lab","pmids":["7681075"],"is_preprint":false},{"year":1993,"finding":"CD2 associates with protein tyrosine kinases p56lck and p59fyn, and with CD3 zeta and epsilon chains, forming a multimolecular signaling complex in T lymphocytes; induction of T cell unresponsiveness (by CD3/TCR modulation) uncouples zeta and epsilon from CD2 while p56lck and p59fyn associations remain, correlating with loss of CD2-mediated proliferation.","method":"In vitro kinase assays on CD2 immunoprecipitates from Brij-58 T lymphocyte lysates; double indirect immunofluorescence with capping","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP/kinase assay with immunofluorescence confirmation, single lab, two complementary methods","pmids":["8093441"],"is_preprint":false},{"year":1994,"finding":"CD2 forms a signaling complex with CD3 zeta chain and the Src-family kinase p59fyn in T lymphocytes, identified by in vitro kinase assays on CD2 immunoprecipitates and confirmed by double indirect immunofluorescence capping in viable T lymphocytes.","method":"In vitro kinase assays; immunoprecipitation; double indirect immunofluorescence capping","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP/kinase assay plus imaging, single lab, two complementary methods","pmids":["7912674"],"is_preprint":false},{"year":1998,"finding":"A cytoplasmic protein CD2BP2 binds directly to two PPPGHR motifs in the CD2 cytoplasmic domain via a novel 17-aa GYF-containing proline-binding module distinct from SH3 and WW domains; over-expression of the CD2BP2 binding domain in Jurkat cells enhances IL-2 production upon CD2 crosslinking but not TCR crosslinking.","method":"Interaction trap cloning; mutagenesis; NMR structure of CD2BP2 binding domain; functional over-expression in Jurkat cells with IL-2 production assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structural analysis with mutagenesis and functional assay, multiple orthogonal methods","pmids":["9843987"],"is_preprint":false},{"year":1998,"finding":"CD2BP1 (a cdc15-like adaptor protein, also called PSTPIP1) binds directly to the CD2 cytoplasmic sequence KGPPLPRPRV via its SH3 domain; upon ligand-induced CD2 clustering, CD2BP1 redistributes from cytosol to the membrane co-localizing with CD2 and downregulates CD2-stimulated adhesion, apparently by coupling PTP-PEST to CD2.","method":"Interaction trap cloning; direct SH3 domain binding assay; immunofluorescence co-localization; CD2 adhesion assays with CD2BP1 expression","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct binding assay, co-localization, and functional adhesion readout, multiple orthogonal methods","pmids":["9857189"],"is_preprint":false},{"year":1998,"finding":"CD2 contains a p56lck-independent signaling pathway; CD2-mediated IL-2 production occurs via activation of Jun kinase (JNK) in cell lines lacking p56lck, with c-Jun/c-Fos binding to the AP-1 site driving IL-2 promoter activity, demonstrating mechanistic divergence between CD2 and TCR signaling.","method":"p56lck-deficient T cell lines; CD2 stimulation; JNK kinase assay; AP-1 transcription factor binding; IL-2 promoter activity","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinase assays and transcription factor assays in genetically defined cell lines, single lab","pmids":["9727049"],"is_preprint":false},{"year":1999,"finding":"CD2 physically associates with CD5 in T lymphocytes independently of CD3; CD2 cross-linking leads to dephosphorylation of CD5 (in contrast to CD3 stimulation which phosphorylates CD5) correlated with enhanced SHP-1 phosphatase activity, identifying CD5 phosphorylation state as a CD2-regulated signaling node.","method":"Co-immunoprecipitation in CD3-deficient and CD2-deficient Jurkat cells; phosphotyrosine western blotting; SHP-1 phosphatase activity assay","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP in genetically defined cell lines plus enzyme activity assay, single lab","pmids":["10510361"],"is_preprint":false},{"year":2000,"finding":"p59fyn is a critical upstream kinase in the CD2 signaling pathway; in fyn-/- mice expressing transgenic human CD2, CD2-induced Ca2+ mobilization, MAPK activation, and T cell proliferation are markedly reduced, while TCR-triggered proliferation is unaffected; CD2 pathway substrates of fyn include PLCγ1, Vav, PKCθ, Dok, FAK, and Pyk2.","method":"Human CD2 transgenic fyn-/- mice; T cell stimulation assays; Ca2+ flux; MAPK assays; substrate phosphorylation analysis; proliferation assays","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout mice with transgenic CD2, multiple orthogonal biochemical readouts, clean separation of CD2 vs. TCR pathways","pmids":["11093170"],"is_preprint":false},{"year":2000,"finding":"CD2 and LFA-1 facilitate T cell activation additively; absence of both CD2-CD48 and LFA-1-ICAM-1 interactions in CD2-deficient mice shifts the antigen dose-response by ~100-fold; CD2 absence affects conjugate formation, TCR triggering, and Ca2+ flux at low antigen density.","method":"CD2-deficient mice crossed with TCR-transgenic mice; T cell-APC conjugate formation assay; TCR triggering assay; Ca2+ flux measurement; in vivo LCMV infection","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with transgenic TCR, multiple mechanistic readouts, in vitro and in vivo","pmids":["10562314"],"is_preprint":false},{"year":2001,"finding":"p62dok is a negative regulator of CD2 signaling; over-expression of p62dok in Jurkat cells inhibits CD2-mediated (but not CD3-mediated) Ca2+ increase, PLCγ1 activation, and ERK1/2 activation; CD2 (but not CD3) stimulation induces p62dok and RasGAP recruitment to the plasma membrane.","method":"Stable over-expression of p62dok in Jurkat cells; Ca2+ flux; PLCγ1 activation assay; ERK1/2 phosphorylation; membrane fractionation; NF-AT reporter assay","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function with multiple signaling readouts specifically dissecting CD2 vs. CD3 pathways, single lab","pmids":["11254695"],"is_preprint":false},{"year":2002,"finding":"CD2AP directly binds filamentous actin (F-actin) through its COOH terminus, acting as a direct adapter between the actin cytoskeleton and membrane proteins such as nephrin and polycystin-2; disruption of the actin cytoskeleton disorganizes endogenous CD2AP distribution.","method":"F-actin coprecipitation assay with purified CD2AP fusion proteins; cytoskeletal fractionation by differential centrifugation; fluorescence co-localization in cultured cells; actin depolymerization experiments","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution (purified proteins), domain mapping, and cellular fractionation, multiple orthogonal methods","pmids":["12217865"],"is_preprint":false},{"year":2002,"finding":"Alefacept (LFA-3/IgG1 fusion protein) mediates apoptosis of CD2+ T cells by bridging CD2 on T cells with CD16 (FcγRIII) on NK cells; signaling is transduced through CD16, not CD2; confirmed using IgG1 CH2 domain Fc mutants that ablate FcγR binding, and in human CD2-transgenic mice.","method":"Alefacept Fc-region amino acid substitution mutants; ERK phosphorylation; CD25 expression; granzyme B release; human CD2-transgenic mouse model","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — mutagenesis of effector function with multiple functional readouts and in vivo mouse model, clean dissection of CD2 vs. CD16 signaling","pmids":["11970990"],"is_preprint":false},{"year":2003,"finding":"Nanoscale increases in intermembrane spacing (from 12.8 nm with CD48-WT to 14.7–15.6 nm with extended CD48 chimeras) reduce CD2-mediated adhesion efficiency 10-fold and reorganize the immunological synapse, sequestering TCR away from its ligand.","method":"CD48 chimeras with additional Ig domains; electron tomography of contact areas; confocal imaging of immunological synapses; quantitative adhesion assays with planar bilayers","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — electron tomography structural measurements combined with functional adhesion and synapse organization assays","pmids":["18826951"],"is_preprint":false},{"year":2005,"finding":"CD2AP is required for cytokinesis in HeLa cells; it localizes to the midbody during telophase (as a membrane-associated, not microtubule-associated, protein), interacts with the cleavage furrow protein anillin (by yeast two-hybrid), and siRNA-mediated knockdown of CD2AP causes cell multinucleation/failure of cell separation; CD2AP is phosphorylated during mitosis.","method":"Immunofluorescence localization; SH3 domain overexpression; siRNA knockdown; yeast two-hybrid; phosphorylation analysis","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — loss-of-function (siRNA) with specific cytokinesis phenotype, yeast two-hybrid interaction, localization data, multiple methods","pmids":["15800069"],"is_preprint":false},{"year":2006,"finding":"CD2 concentrates in a large T cell invagination at the center of the T cell-APC interface within 1 minute of contact formation; dissolution of this invagination and CD2 engagement are required for effective proximal TCR signaling; CD2 is the most prominently internalized receptor in this structure.","method":"Live fluorescence microscopy of T cell-APC conjugates; antibody blocking; quantitative receptor tracking","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live imaging with functional signaling readout, single lab","pmids":["16982875"],"is_preprint":false},{"year":2006,"finding":"T cell activation causes a 1.5-fold increase in cell-surface CD2 numbers, a 2.5-fold increase in 2D affinity for CD58, and immobilization of ligated CD2 at the contact zone (reduced lateral mobility); these combined changes substantially enhance CD2 avidity and strengthen T cell-APC adhesion.","method":"Quantitative fluorescence imaging of CD2 numbers; 2D affinity measurement; FRAP of CD2 on resting vs. activated T cells","journal":"ACS chemical biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative biophysical measurements, single lab, multiple parameters","pmids":["17168569"],"is_preprint":false},{"year":2007,"finding":"CD2-CD58 interaction synergizes with TCR to activate PLC-γ1 at the immunological synapse; blocking CD2-CD58 interaction reduces PLCγ1 recruitment to the IS and impairs phosphorylation of PLCγ1 at regulatory Tyr783, demonstrating that CD2 costimulation enhances TCR-induced calcium signaling through PLCγ1.","method":"Anti-CD58 antibody blocking; single-cell Ca2+ imaging; PLCγ1 immunofluorescence at IS; phospho-PLCγ1 (Tyr783) western blot","journal":"International immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — blocking experiment with multiple downstream signaling readouts, single lab","pmids":["17220479"],"is_preprint":false},{"year":2009,"finding":"CD2 ligation by CD58 (in the absence of TCR activation) induces signaling through actin-dependent coalescence of TCR-ζ, Lck, and LAT into plasma membrane microdomains; when TCR and CD2 are co-activated, they initially co-localize then spatially segregate into separate zones, potentially enabling synergistic signaling.","method":"Jurkat T cells on planar lipid bilayers (CD58 only, without TCR ligand); single-molecule tracking; live TIRF microscopy; co-localization analysis","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — single-molecule live imaging with a defined reconstituted system, multiple signaling molecules tracked, mechanistically informative","pmids":["19398758"],"is_preprint":false},{"year":2009,"finding":"CD2 acts as a master adaptor linking Lck and CD48 to the TCR/CD3 complex during T cell activation; CD48 (GPI-anchored) is recruited to the immobilized TCR/CD3 complex in a CD2-dependent manner, and CD48 in turn recruits LAT to the TCR complex, establishing a hierarchical CD2→CD48→LAT signaling relay.","method":"Co-immunoprecipitation of TCR/CD3 complex with CD2, CD48, LAT, and Lck; T cell IL-2 production assays; knockdown experiments; CD2- and CD48-deficient cell analysis","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with defined order of epistasis, single lab","pmids":["19494291"],"is_preprint":false},{"year":2012,"finding":"CD2-CD58/48 receptor-ligand interaction is required for membrane nanotube formation by human NK cells; stable CD2 expression in CD2-negative NK cell line YTS enables nanotube formation and improves cytotoxic function; CD2 localizes to nanotube tips; blocking CD2 receptor-ligand interactions prevents nanotube formation.","method":"Stable CD2 transfection into CD2-negative YTS NK cells; quantitative live-cell fluorescence microscopy; blocking antibodies; cytotoxicity assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function and blocking experiments with quantitative live imaging and functional cytotoxicity readout, single lab","pmids":["23112830"],"is_preprint":false},{"year":2020,"finding":"CD2 localizes to the outer edge of the mature immunological synapse (the 'CD2 corolla'), where it captures engaged co-stimulatory receptors (CD28, ICOS, CD226, SLAM-F1) and amplifies active phosphorylated SFK, LAT, and PLC-γ signaling by 77% compared to central CD2; corolla formation depends on CD2 copy number and specific cytoplasmic tail motifs; PD-1 invades the corolla and buffers CD2-mediated signaling amplification.","method":"Super-resolution imaging and confocal microscopy of IS with primary human T cells and artificial APCs; CD2 copy number manipulation; cytoplasmic tail truncation mutants; pSFK/LAT/PLCγ quantification; PD-1 co-engagement experiments","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple imaging modalities, mutagenesis of cytoplasmic tail, quantitative signaling readouts, and mechanistic intervention experiments in primary cells","pmids":["32929275"],"is_preprint":false},{"year":2020,"finding":"CD2 costimulation drives AMPK-dependent polarization of lytic granules toward the MTOC in CD8+ CTLs; phosphoproteomics revealed 616 CD2-regulated phosphorylation events including AMPK pathway activation; AMPK enriched on lysosomes adjacent to granules drives this polarization.","method":"Phosphoproteomics of CD2-stimulated primary human CD8+ T cells; AMPK activity assays; lytic granule polarization imaging; lysosome-granule proximity analysis; functional cytotoxicity assays","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 2 / Moderate — phosphoproteomics with functional validation of AMPK-granule axis in primary cells, multiple methods","pmids":["32398348"],"is_preprint":false},{"year":2022,"finding":"CD2-CD48 cis interactions (within the same T cell membrane) are required for T cell activation; CD48 on APCs is dispensable for T cell activation (except during cytotoxicity), while T cell-intrinsic CD48 is necessary; FRET confirmed CD2-CD48 cis interactions in non-immune cells; mass spectrometry of CD2 knock-in T cells revealed that CD2 interacts with TCR complex components and Lck, correlating CD2 function with its association with the TCR signalosome.","method":"New CD2 and CD48 knockout mouse strains; FRET in non-immune cells; mass spectrometry of CD2 tag knock-in T cells; TCR signaling (protein tyrosine phosphorylation) assays; cytotoxicity assays","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — new genetic knockouts with FRET demonstration of cis interactions, mass spectrometry interactome, multiple functional readouts, rigorous study design","pmids":["35930657"],"is_preprint":false}],"current_model":"CD2 is a T and NK cell surface glycoprotein that functions as both an adhesion molecule and a signaling co-receptor: its extracellular domain binds LFA-3/CD58 (in humans) or CD48 (in mice) in trans on APCs and also in cis on the same T cell, with cis CD2-CD48 interactions being required for TCR signaling; its cytoplasmic domain contains distinct regions for signal transduction (requiring CD3ζ and p59fyn) and for regulated avidity (requiring the COOH-terminal asparagine), and engages adaptor proteins CD2BP1 (via proline-rich motifs/SH3) and CD2BP2 (via a GYF motif); upon ligand engagement CD2 recruits Lck, CD3ζ/ε, and p59fyn into a signaling complex, activates PLCγ1, JNK, and AMPK pathways, localizes to the outer CD2 corolla of the immunological synapse to amplify TCR-proximal signaling by ~77%, and drives lytic granule polarization toward the MTOC in cytotoxic T cells."},"narrative":{"mechanistic_narrative":"CD2 is a T and NK cell surface immunoglobulin-superfamily glycoprotein that functions both as an adhesion molecule and as a costimulatory amplifier of antigen-receptor signaling [PMID:2951597, PMID:3102975, PMID:2566919, PMID:10562314]. Its membrane-distal extracellular domain binds the GPI-anchored counter-receptor LFA-3/CD58 in humans and CD48 in mice through a hypervariable-like region of its first Ig domain, an interaction that requires N-glycosylation at Asn65 to maintain the binding-competent fold [PMID:2951597, PMID:3102975, PMID:3313052, PMID:2444890, PMID:1383383, PMID:1385399]. This adhesion is constitutively active at rest and complements the inducible LFA-1 system; TCR engagement subsequently increases CD2 surface number, 2D affinity, and immobilization at the contact zone to strengthen conjugate formation, a regulated avidity that depends on the COOH-terminal asparagine of the cytoplasmic tail and is mechanistically separable from CD2's signaling output [PMID:2566919, PMID:1672642, PMID:1353888, PMID:7901319, PMID:17168569]. The cytoplasmic domain couples ligand engagement to the TCR signalosome: CD2 associates with CD3ζ/ε and the Src-family kinases p56lck and p59fyn, and CD3ζ is the essential downstream subunit transducing CD2 signals in both T and NK cells, with p59fyn acting as the critical upstream kinase phosphorylating PLCγ1, Vav, and other substrates [PMID:1351920, PMID:1346934, PMID:8093441, PMID:11093170]. Through this complex CD2 synergizes with the TCR to drive PLCγ1 activation, calcium flux, and IL-2 production, and recent work places CD2-CD48 cis interactions on the same T cell membrane—rather than trans engagement of APC ligand—as the requirement for activation [PMID:17220479, PMID:19494291, PMID:35930657]. The tail also engages dedicated adaptors: CD2BP2 binds PPPGHR motifs via a GYF module to enhance CD2-specific IL-2 output, while CD2BP1/PSTPIP1 binds via its SH3 domain and downregulates adhesion by coupling PTP-PEST to clustered CD2 [PMID:9843987, PMID:9857189]. Spatially, CD2 concentrates at the immunological synapse, forming an outer 'CD2 corolla' that captures costimulatory receptors and amplifies proximal SFK/LAT/PLCγ signaling, and CD2 costimulation drives AMPK-dependent polarization of lytic granules toward the MTOC in cytotoxic T cells [PMID:32929275, PMID:32398348]. (Findings concerning CD2AP—actin binding, nephrin/polycystin linkage, and cytokinesis [PMID:12217865, PMID:15800069]—describe a distinct protein and are not part of CD2 receptor biology.)","teleology":[{"year":1987,"claim":"Establishing that CD2 is a high-affinity adhesion receptor for LFA-3/CD58 defined its founding molecular function and placed both partners in the Ig superfamily.","evidence":"Purified-protein binding and rosetting inhibition assays; cDNA cloning and sequence analysis of LFA-3","pmids":["2951597","3102975","3313052"],"confidence":"High","gaps":["Did not localize the binding interface on CD2","Did not establish whether adhesion contributes to signaling"]},{"year":1987,"claim":"Mapping the LFA-3 site to the first Ig domain and showing natural ligand delivers an activation signal connected adhesion structure to function and to the 'alternative pathway' of T cell activation.","evidence":"Systematic CD2 mutagenesis with binding readouts; T cell stimulation with natural ligand and activating antibodies","pmids":["2444890","3102975"],"confidence":"High","gaps":["Did not define the cytoplasmic signaling machinery","Did not separate adhesion from signal transduction"]},{"year":1988,"claim":"Demonstrating that CD2 activation requires an intact CD3-Ti complex established interdependence between the CD2 and TCR pathways rather than fully independent signaling.","evidence":"CD3-Ti-negative Jurkat mutants with phosphoinositide/Ca2+/IL-2 readouts and TCR reconstitution rescue","pmids":["2901344"],"confidence":"High","gaps":["Did not identify which TCR subunit is the coupling element","Did not address adhesion-only contributions"]},{"year":1989,"claim":"Showing that cytoplasmic-tailless CD2 still enhances antigen-specific responses dissected adhesion per se from signal transduction as separable contributors to activation.","evidence":"CD2 cytoplasmic truncation mutants in antigen-specific hybridomas with LFA-3+ APCs","pmids":["2566919"],"confidence":"High","gaps":["Did not define the signaling motifs in the retained vs. deleted tail"]},{"year":1991,"claim":"Biophysical reconstitution showed ligand lateral mobility strengthens CD2 adhesion and that CD2 adhesion is constitutively active, distinguishing it from inducible LFA-1.","evidence":"Planar bilayers with GPI vs. transmembrane LFA-3, FRAP, flow adhesion assays; pharmacological modulation of adhesion","pmids":["1717480","1672642"],"confidence":"High","gaps":["Did not connect adhesion strength to downstream signaling magnitude in primary cells"]},{"year":1992,"claim":"Chimeric-receptor reconstitution identified CD3ζ as the necessary and sufficient subunit coupling CD2 to signaling in both T and NK cells, resolving the coupling element left open in 1988.","evidence":"CD8α/CD3ζ and CD16 chimeras in TCR-negative Jurkat with Ca2+, PTK, and IL-2 readouts; wild-type vs. truncated CD3ζ","pmids":["1351920","1346934"],"confidence":"High","gaps":["Did not define the physical linkage between CD2 tail and CD3ζ","Did not enumerate the kinases recruited"]},{"year":1992,"claim":"Identifying CD48 as the mouse counter-receptor and Asn65/N-glycan as essential for ligand binding completed the ligand map and defined a glycan-dependent adhesion fold.","evidence":"CD2-Ig fusion screening with microsequencing and blocking; deglycosylation and Asn65→Gln mutagenesis with binding/MS","pmids":["1383383","1385399"],"confidence":"High","gaps":["Did not address cis vs. trans engagement of CD48"]},{"year":1992,"claim":"Defining TCR-induced avidity regulation and pinning it to the COOH-terminal asparagine revealed a dynamic adhesion-tuning function distinct from CD2 signaling output.","evidence":"CD2 cytoplasmic point/deletion mutants in T cell lines with CD58-avidity and antigen-proliferation assays","pmids":["1353888","7901319"],"confidence":"High","gaps":["Did not identify the trans-acting regulator binding the C-terminal asparagine region"]},{"year":1993,"claim":"Co-IP/kinase work assembled the CD2 signaling complex (p56lck, p59fyn, CD3ζ/ε) and linked avidity upregulation to PTK/PKC/cAMP inputs converging on the C-terminal asparagine.","evidence":"In vitro kinase assays on CD2 immunoprecipitates, immunofluorescence capping; pharmacological PTK/PKC/cAMP dissection with mutants","pmids":["8093441","7912674","7681075"],"confidence":"Medium","gaps":["Co-IP associations not reconstituted to establish directness","Single-lab kinase assays"]},{"year":1998,"claim":"Cloning CD2BP2 and CD2BP1/PSTPIP1 identified dedicated tail adaptors with opposing effects on CD2 signaling vs. adhesion, defining a proline-motif-based regulatory module.","evidence":"Interaction trap cloning, NMR of CD2BP2 GYF domain, SH3 binding assays, co-localization, IL-2 and adhesion readouts","pmids":["9843987","9857189"],"confidence":"High","gaps":["Did not establish how adaptor engagement is temporally regulated during synapse formation"]},{"year":1998,"claim":"Demonstrating a p56lck-independent JNK/AP-1 arm of CD2 signaling showed mechanistic divergence between CD2 and TCR signaling beyond shared components.","evidence":"CD2 stimulation in p56lck-deficient lines with JNK assay, AP-1 binding, and IL-2 promoter reporter","pmids":["9727049"],"confidence":"Medium","gaps":["Did not identify the kinase relay upstream of JNK in the absence of Lck","Single-lab study"]},{"year":1999,"claim":"Identifying CD2-induced CD5 dephosphorylation and SHP-1 activation, and later p62dok recruitment, exposed negative-regulatory nodes specific to CD2 signaling.","evidence":"Reciprocal co-IP in CD3/CD2-deficient Jurkat with SHP-1 activity; p62dok overexpression with Ca2+/PLCγ1/ERK readouts","pmids":["10510361","11254695"],"confidence":"Medium","gaps":["Did not establish physiological roles in primary T cells","Single-lab gain/loss studies"]},{"year":2000,"claim":"Genetic knockout and transgenic models established p59fyn as the critical CD2 kinase and quantified CD2's additive contribution with LFA-1 to lowering the antigen activation threshold.","evidence":"Human CD2-transgenic fyn-/- mice and CD2-deficient TCR-transgenic mice with Ca2+, MAPK, conjugate, and in vivo LCMV readouts","pmids":["11093170","10562314"],"confidence":"High","gaps":["Did not resolve spatial organization of CD2 signaling at the synapse"]},{"year":2003,"claim":"Showing that nanoscale intermembrane spacing controls CD2 adhesion and synapse organization linked CD2 dimensions directly to TCR triggering geometry.","evidence":"Extended CD48 chimeras with electron tomography, confocal synapse imaging, and bilayer adhesion assays","pmids":["18826951"],"confidence":"High","gaps":["Did not map the molecular sensors that read intermembrane distance"]},{"year":2006,"claim":"Live imaging revealed CD2 concentration in an early central invagination and quantified the activation-induced increases in CD2 number, 2D affinity, and immobilization underlying avidity enhancement.","evidence":"Live microscopy of T cell-APC conjugates; quantitative imaging, 2D affinity measurement, and FRAP","pmids":["16982875","17168569"],"confidence":"Medium","gaps":["Single-lab imaging studies","Did not directly link invagination dynamics to defined signaling molecules"]},{"year":2009,"claim":"Single-molecule and reconstitution studies placed CD2 as an actin-dependent organizer that coalesces TCRζ/Lck/LAT microdomains and relays CD2→CD48→LAT to the TCR signalosome.","evidence":"Jurkat on CD58-only bilayers with single-molecule TIRF tracking; co-IP epistasis of CD2/CD48/LAT/Lck with IL-2 assays","pmids":["19398758","19494291"],"confidence":"Medium","gaps":["Co-IP epistasis not reconstituted with purified components","Did not resolve cis vs. trans CD48 source"]},{"year":2012,"claim":"CD2-CD48/CD58 interaction was shown to be required for NK cell membrane nanotube formation and cytotoxic function, extending CD2's role to NK effector architecture.","evidence":"Stable CD2 expression in CD2-negative YTS cells, blocking antibodies, live imaging, cytotoxicity assays","pmids":["23112830"],"confidence":"Medium","gaps":["Single-lab study","Did not define the signaling pathway driving nanotube formation"]},{"year":2020,"claim":"Super-resolution imaging and phosphoproteomics defined the outer 'CD2 corolla' that captures costimulatory receptors to amplify proximal signaling and a CD2-driven AMPK axis polarizing lytic granules toward the MTOC.","evidence":"Super-resolution/confocal IS imaging with copy-number and tail-truncation manipulation; phosphoproteomics with AMPK and granule-polarization functional validation in primary human T cells","pmids":["32929275","32398348"],"confidence":"High","gaps":["Did not fully define the tail motifs controlling corolla formation at residue level","Mechanism of AMPK enrichment on granule-adjacent lysosomes not resolved"]},{"year":2022,"claim":"New knockouts, FRET, and CD2 interactome mass spectrometry redefined the activation requirement as CD2-CD48 cis interactions on the T cell, with CD2 physically associating with the TCR complex and Lck.","evidence":"CD2 and CD48 knockout mouse strains, FRET in non-immune cells, mass spectrometry of CD2 knock-in T cells, TCR phosphorylation and cytotoxicity assays","pmids":["35930657"],"confidence":"High","gaps":["Did not structurally resolve the cis CD2-CD48 complex","Did not reconcile cis requirement with prior trans-adhesion models mechanistically"]},{"year":null,"claim":"How CD2 cytoplasmic-tail motifs, cis CD48 engagement, and corolla positioning are integrated into a single physical mechanism that couples adhesion geometry to TCR-proximal signaling amplification remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of the assembled CD2 signaling complex with CD3ζ/Lck","Quantitative rules linking corolla composition to signal amplification undefined","Reconciliation of cis vs. trans CD2-CD48 engagement in vivo incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,5,7,8,23]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[2,9,10,22,31]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[33,37]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[12,14,35]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,16,19,29,32,35]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,9,22,23,35,36]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,22,31,33]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[0,23,27]}],"complexes":["TCR/CD3-CD2 signaling complex","CD2 corolla"],"partners":["CD58","CD48","CD3Z","FYN","LCK","CD2BP2","PSTPIP1","CD5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P06729","full_name":"T-cell surface antigen CD2","aliases":["Erythrocyte receptor","LFA-2","LFA-3 receptor","Rosette receptor","T-cell surface antigen T11/Leu-5"],"length_aa":351,"mass_kda":39.4,"function":"CD2 interacts with lymphocyte function-associated antigen CD58 (LFA-3) and CD48/BCM1 to mediate adhesion between T-cells and other cell types. CD2 is implicated in the triggering of T-cells, the cytoplasmic domain is implicated in the signaling function","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P06729/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CD2","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CD2","total_profiled":1310},"omim":[{"mim_id":"616714","title":"HMG-BOX TRANSCRIPTION FACTOR 1; HBP1","url":"https://www.omim.org/entry/616714"},{"mim_id":"615707","title":"IMMUNODEFICIENCY 20; IMD20","url":"https://www.omim.org/entry/615707"},{"mim_id":"615615","title":"IMMUNODEFICIENCY 18; IMD18","url":"https://www.omim.org/entry/615615"},{"mim_id":"615122","title":"LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2","url":"https://www.omim.org/entry/615122"},{"mim_id":"612268","title":"TUBULIN TYROSINE LIGASE-LIKE 5; TTLL5","url":"https://www.omim.org/entry/612268"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Golgi apparatus","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":232.5}],"url":"https://www.proteinatlas.org/search/CD2"},"hgnc":{"alias_symbol":[],"prev_symbol":["SRBC"]},"alphafold":{"accession":"P06729","domains":[{"cath_id":"2.60.40.10","chopping":"26-126","consensus_level":"high","plddt":94.4352,"start":26,"end":126},{"cath_id":"2.60.40.10","chopping":"133-202","consensus_level":"high","plddt":96.2903,"start":133,"end":202},{"cath_id":"1.20.5","chopping":"207-244","consensus_level":"medium","plddt":85.5232,"start":207,"end":244}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P06729","model_url":"https://alphafold.ebi.ac.uk/files/AF-P06729-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P06729-F1-predicted_aligned_error_v6.png","plddt_mean":77.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CD2","jax_strain_url":"https://www.jax.org/strain/search?query=CD2"},"sequence":{"accession":"P06729","fasta_url":"https://rest.uniprot.org/uniprotkb/P06729.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P06729/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P06729"}},"corpus_meta":[{"pmid":"3313052","id":"PMC_3313052","title":"An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2.","date":"1987","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/3313052","citation_count":742,"is_preprint":false},{"pmid":"2951597","id":"PMC_2951597","title":"The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3.","date":"1987","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/2951597","citation_count":520,"is_preprint":false},{"pmid":"3102975","id":"PMC_3102975","title":"Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand.","date":"1987","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/3102975","citation_count":275,"is_preprint":false},{"pmid":"1383383","id":"PMC_1383383","title":"CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation.","date":"1992","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1383383","citation_count":247,"is_preprint":false},{"pmid":"2566919","id":"PMC_2566919","title":"CD2-mediated adhesion facilitates T lymphocyte antigen recognition function.","date":"1989","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/2566919","citation_count":241,"is_preprint":false},{"pmid":"1970422","id":"PMC_1970422","title":"Association of CD2 and CD45 on human T lymphocytes.","date":"1990","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1970422","citation_count":184,"is_preprint":false},{"pmid":"1717480","id":"PMC_1717480","title":"Influence of receptor lateral mobility on adhesion strengthening between membranes containing LFA-3 and CD2.","date":"1991","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1717480","citation_count":174,"is_preprint":false},{"pmid":"3102667","id":"PMC_3102667","title":"Similarities in sequences and cellular expression between rat CD2 and CD4 antigens.","date":"1987","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/3102667","citation_count":169,"is_preprint":false},{"pmid":"2444890","id":"PMC_2444890","title":"Monoclonal antibody and ligand binding sites of the T cell erythrocyte receptor (CD2).","date":"1987","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/2444890","citation_count":162,"is_preprint":false},{"pmid":"2576417","id":"PMC_2576417","title":"The structural biology of CD2.","date":"1989","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/2576417","citation_count":161,"is_preprint":false},{"pmid":"11698418","id":"PMC_11698418","title":"Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11698418","citation_count":159,"is_preprint":false},{"pmid":"2901344","id":"PMC_2901344","title":"Interdependence of CD3-Ti and CD2 activation pathways in human T lymphocytes.","date":"1988","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/2901344","citation_count":153,"is_preprint":false},{"pmid":"2901953","id":"PMC_2901953","title":"The structure of the human CD2 gene and its expression in transgenic mice.","date":"1988","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/2901953","citation_count":149,"is_preprint":false},{"pmid":"1358605","id":"PMC_1358605","title":"Development and function of T cells in mice with a disrupted CD2 gene.","date":"1992","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/1358605","citation_count":143,"is_preprint":false},{"pmid":"12217865","id":"PMC_12217865","title":"CD2-associated protein directly interacts with the actin cytoskeleton.","date":"2002","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12217865","citation_count":129,"is_preprint":false},{"pmid":"32582179","id":"PMC_32582179","title":"CD2 Immunobiology.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32582179","citation_count":124,"is_preprint":false},{"pmid":"9700513","id":"PMC_9700513","title":"CD2 and the nature of protein interactions mediating cell-cell recognition.","date":"1998","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/9700513","citation_count":121,"is_preprint":false},{"pmid":"32929275","id":"PMC_32929275","title":"A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals.","date":"2020","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32929275","citation_count":107,"is_preprint":false},{"pmid":"2462499","id":"PMC_2462499","title":"Unusual expression of CD2 in sheep: implications for T cell interactions.","date":"1988","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2462499","citation_count":106,"is_preprint":false},{"pmid":"1682413","id":"PMC_1682413","title":"Anti-CD2 antibodies induce T cell unresponsiveness in vivo.","date":"1991","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1682413","citation_count":100,"is_preprint":false},{"pmid":"10562314","id":"PMC_10562314","title":"CD2 sets quantitative thresholds in T cell activation.","date":"1999","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10562314","citation_count":99,"is_preprint":false},{"pmid":"1346934","id":"PMC_1346934","title":"CD3 zeta dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1346934","citation_count":99,"is_preprint":false},{"pmid":"11970990","id":"PMC_11970990","title":"Alefacept, an immunomodulatory recombinant LFA-3/IgG1 fusion protein, induces CD16 signaling and CD2/CD16-dependent apoptosis of CD2(+) cells.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11970990","citation_count":98,"is_preprint":false},{"pmid":"1353379","id":"PMC_1353379","title":"Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia.","date":"1992","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/1353379","citation_count":97,"is_preprint":false},{"pmid":"7903681","id":"PMC_7903681","title":"Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival.","date":"1994","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/7903681","citation_count":95,"is_preprint":false},{"pmid":"19398758","id":"PMC_19398758","title":"The coreceptor CD2 uses plasma membrane microdomains to transduce signals in T cells.","date":"2009","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19398758","citation_count":90,"is_preprint":false},{"pmid":"9843987","id":"PMC_9843987","title":"Identification of a proline-binding motif regulating CD2-triggered T lymphocyte activation.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9843987","citation_count":88,"is_preprint":false},{"pmid":"1672642","id":"PMC_1672642","title":"Complementary roles for CD2 and LFA-1 adhesion pathways during T cell activation.","date":"1991","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1672642","citation_count":80,"is_preprint":false},{"pmid":"9857189","id":"PMC_9857189","title":"A cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9857189","citation_count":79,"is_preprint":false},{"pmid":"7544396","id":"PMC_7544396","title":"CD2 regulates responsiveness of activated T cells to interleukin 12.","date":"1995","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/7544396","citation_count":78,"is_preprint":false},{"pmid":"1351920","id":"PMC_1351920","title":"The CD3 zeta cytoplasmic domain mediates CD2-induced T cell activation.","date":"1992","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1351920","citation_count":74,"is_preprint":false},{"pmid":"15800069","id":"PMC_15800069","title":"Clues to CD2-associated protein involvement in cytokinesis.","date":"2005","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15800069","citation_count":64,"is_preprint":false},{"pmid":"12031800","id":"PMC_12031800","title":"Studies on the interaction between Cd(2+) ions and DNA.","date":"2002","source":"Journal of inorganic biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12031800","citation_count":64,"is_preprint":false},{"pmid":"14643126","id":"PMC_14643126","title":"CD2-associated protein and glomerular disease.","date":"2003","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/14643126","citation_count":62,"is_preprint":false},{"pmid":"1764062","id":"PMC_1764062","title":"Cadmium (Cd2+) disrupts Ca(2+)-dependent cell-cell junctions and alters the pattern of E-cadherin immunofluorescence in LLC-PK1 cells.","date":"1991","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/1764062","citation_count":61,"is_preprint":false},{"pmid":"18826951","id":"PMC_18826951","title":"Nanoscale increases in CD2-CD48-mediated intermembrane spacing decrease adhesion and reorganize the immunological synapse.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18826951","citation_count":58,"is_preprint":false},{"pmid":"10725714","id":"PMC_10725714","title":"Coordinate regulation of T cell activation by CD2 and CD28.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10725714","citation_count":57,"is_preprint":false},{"pmid":"10570278","id":"PMC_10570278","title":"Circulating CD2+ monocytes are dendritic cells.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10570278","citation_count":57,"is_preprint":false},{"pmid":"1353888","id":"PMC_1353888","title":"A distinct cytoplasmic domain of CD2 regulates ligand avidity and T-cell responsiveness to antigen.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1353888","citation_count":56,"is_preprint":false},{"pmid":"11313408","id":"PMC_11313408","title":"Cloning, expression, and function of BLAME, a novel member of the CD2 family.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11313408","citation_count":54,"is_preprint":false},{"pmid":"2461308","id":"PMC_2461308","title":"Role of CD2 cross-linking in cytoplasmic calcium responses and T cell activation.","date":"1988","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2461308","citation_count":54,"is_preprint":false},{"pmid":"1385399","id":"PMC_1385399","title":"N-glycosylation is required for human CD2 immunoadhesion functions.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1385399","citation_count":53,"is_preprint":false},{"pmid":"7729601","id":"PMC_7729601","title":"Mammalian CD2 is an effective heterologous marker of the cell surface in Drosophila.","date":"1995","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/7729601","citation_count":52,"is_preprint":false},{"pmid":"8473043","id":"PMC_8473043","title":"Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region.","date":"1993","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/8473043","citation_count":51,"is_preprint":false},{"pmid":"15951437","id":"PMC_15951437","title":"CD2-associated protein (CD2AP) expression in podocytes rescues lethality of CD2AP deficiency.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15951437","citation_count":50,"is_preprint":false},{"pmid":"1674520","id":"PMC_1674520","title":"CD2 can mediate TCR/CD3-independent T cell activation.","date":"1991","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1674520","citation_count":49,"is_preprint":false},{"pmid":"2895149","id":"PMC_2895149","title":"Identification of a CD2- CD3+ T cell receptor-gamma+ peripheral blood lymphocyte subpopulation.","date":"1988","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2895149","citation_count":48,"is_preprint":false},{"pmid":"35930657","id":"PMC_35930657","title":"Cis interactions between CD2 and its ligands on T cells are required for T cell activation.","date":"2022","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35930657","citation_count":47,"is_preprint":false},{"pmid":"12668431","id":"PMC_12668431","title":"Forced detachment of the CD2-CD58 complex.","date":"2003","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12668431","citation_count":45,"is_preprint":false},{"pmid":"2575032","id":"PMC_2575032","title":"Expression and function of CD2 during murine thymocyte ontogeny.","date":"1989","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2575032","citation_count":44,"is_preprint":false},{"pmid":"7681075","id":"PMC_7681075","title":"Signal transduction pathways involved in T cell receptor-induced regulation of CD2 avidity for CD58.","date":"1993","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7681075","citation_count":43,"is_preprint":false},{"pmid":"2565352","id":"PMC_2565352","title":"Distribution and ontogeny of CD2 expression by murine T cells.","date":"1989","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2565352","citation_count":42,"is_preprint":false},{"pmid":"8102249","id":"PMC_8102249","title":"CD2 expression on murine intestinal intraepithelial lymphocytes is bimodal and defines proliferative capacity.","date":"1993","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8102249","citation_count":41,"is_preprint":false},{"pmid":"2894031","id":"PMC_2894031","title":"Exon-intron organization and sequence comparison of human and murine T11 (CD2) genes.","date":"1988","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2894031","citation_count":41,"is_preprint":false},{"pmid":"19494291","id":"PMC_19494291","title":"Sequential cooperation of CD2 and CD48 in the buildup of the early TCR signalosome.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19494291","citation_count":40,"is_preprint":false},{"pmid":"7901319","id":"PMC_7901319","title":"Separable portions of the CD2 cytoplasmic domain involved in signaling and ligand avidity regulation.","date":"1993","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/7901319","citation_count":40,"is_preprint":false},{"pmid":"7693022","id":"PMC_7693022","title":"T cell adhesion, avidity regulation and signaling: a molecular analysis of CD2.","date":"1993","source":"Seminars in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7693022","citation_count":39,"is_preprint":false},{"pmid":"17168569","id":"PMC_17168569","title":"Mechanisms of Cellular Avidity Regulation in CD2-CD58-Mediated T Cell Adhesion.","date":"2006","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/17168569","citation_count":39,"is_preprint":false},{"pmid":"9282312","id":"PMC_9282312","title":"Cadmium (Cd2+) disrupts E-cadherin-dependent cell-cell junctions in MDCK cells.","date":"1997","source":"In vitro cellular & developmental biology. Animal","url":"https://pubmed.ncbi.nlm.nih.gov/9282312","citation_count":38,"is_preprint":false},{"pmid":"2901966","id":"PMC_2901966","title":"Evidence that protein kinase C differentially regulates the human T lymphocyte CD2 and CD3 surface antigens.","date":"1988","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2901966","citation_count":38,"is_preprint":false},{"pmid":"7912674","id":"PMC_7912674","title":"Identification of a signaling complex involving CD2, zeta chain and p59fyn in T lymphocytes.","date":"1994","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7912674","citation_count":38,"is_preprint":false},{"pmid":"11132158","id":"PMC_11132158","title":"Ly108: a new member of the mouse CD2 family of cell surface proteins.","date":"2000","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/11132158","citation_count":38,"is_preprint":false},{"pmid":"3084290","id":"PMC_3084290","title":"CD2 and CD3 antigens mobilize Ca2+ independently.","date":"1986","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/3084290","citation_count":37,"is_preprint":false},{"pmid":"17220479","id":"PMC_17220479","title":"CD2 and TCR synergize for the activation of phospholipase Cgamma1/calcium pathway at the immunological synapse.","date":"2007","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17220479","citation_count":36,"is_preprint":false},{"pmid":"21094032","id":"PMC_21094032","title":"The role of SLAM/CD2 polymorphisms in systemic autoimmunity.","date":"2010","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21094032","citation_count":35,"is_preprint":false},{"pmid":"1691222","id":"PMC_1691222","title":"Expression and ontogeny of CD2 on murine B cells.","date":"1990","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1691222","citation_count":34,"is_preprint":false},{"pmid":"8093441","id":"PMC_8093441","title":"Alterations of CD2 association with T cell receptor signaling molecules in \"CD2 unresponsive\" human T lymphocytes.","date":"1993","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8093441","citation_count":33,"is_preprint":false},{"pmid":"27337048","id":"PMC_27337048","title":"Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein-Protein Interaction.","date":"2016","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/27337048","citation_count":33,"is_preprint":false},{"pmid":"2577288","id":"PMC_2577288","title":"CD2 expression in murine B cell lineage.","date":"1989","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2577288","citation_count":32,"is_preprint":false},{"pmid":"2569403","id":"PMC_2569403","title":"Expression and ontogeny of murine CD2.","date":"1989","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2569403","citation_count":32,"is_preprint":false},{"pmid":"11093170","id":"PMC_11093170","title":"A critical role for p59(fyn) in CD2-based signal transduction.","date":"2000","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11093170","citation_count":32,"is_preprint":false},{"pmid":"11254695","id":"PMC_11254695","title":"p62dok negatively regulates CD2 signaling in Jurkat cells.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11254695","citation_count":31,"is_preprint":false},{"pmid":"29729186","id":"PMC_29729186","title":"CD2-Associated Protein Contributes to Hepatitis C, Virus Propagation and Steatosis by Disrupting Insulin Signaling.","date":"2018","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/29729186","citation_count":30,"is_preprint":false},{"pmid":"9824509","id":"PMC_9824509","title":"Expression of CD2 on porcine B lymphocytes.","date":"1998","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9824509","citation_count":30,"is_preprint":false},{"pmid":"29904386","id":"PMC_29904386","title":"Costimulatory Function of Cd58/Cd2 Interaction in Adaptive Humoral Immunity in a Zebrafish Model.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29904386","citation_count":30,"is_preprint":false},{"pmid":"11174380","id":"PMC_11174380","title":"CD2- CD4+ CD56+ hematodermic/hematolymphoid malignancy.","date":"2001","source":"Journal of the American Academy of Dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/11174380","citation_count":29,"is_preprint":false},{"pmid":"16323413","id":"PMC_16323413","title":"The CD2 family of natural killer cell receptors.","date":"2006","source":"Current topics in microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16323413","citation_count":29,"is_preprint":false},{"pmid":"21755948","id":"PMC_21755948","title":"Conformationally constrained peptides from CD2 to modulate protein-protein interactions between CD2 and CD58.","date":"2011","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21755948","citation_count":29,"is_preprint":false},{"pmid":"16982875","id":"PMC_16982875","title":"A large T cell invagination with CD2 enrichment resets receptor engagement in the immunological synapse.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16982875","citation_count":29,"is_preprint":false},{"pmid":"12714509","id":"PMC_12714509","title":"CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12714509","citation_count":29,"is_preprint":false},{"pmid":"2567000","id":"PMC_2567000","title":"Chromatin configuration of the human CD2 gene locus during T-cell development.","date":"1989","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2567000","citation_count":29,"is_preprint":false},{"pmid":"26841241","id":"PMC_26841241","title":"MYO3A Causes Human Dominant Deafness and Interacts with Protocadherin 15-CD2 Isoform.","date":"2016","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/26841241","citation_count":29,"is_preprint":false},{"pmid":"1684171","id":"PMC_1684171","title":"Regulation of T-cell differentiation by CD2 and CD28 accessory molecules.","date":"1991","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1684171","citation_count":28,"is_preprint":false},{"pmid":"16803907","id":"PMC_16803907","title":"Crystal structure and binding properties of the CD2 and CD244 (2B4)-binding protein, CD48.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16803907","citation_count":28,"is_preprint":false},{"pmid":"1673843","id":"PMC_1673843","title":"Defective CD2 pathway T cell activation in systemic lupus erythematosus.","date":"1991","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/1673843","citation_count":28,"is_preprint":false},{"pmid":"24218450","id":"PMC_24218450","title":"CD2-associated protein regulates plasmacytoid dendritic cell migration, but is dispensable for their development and cytokine production.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24218450","citation_count":27,"is_preprint":false},{"pmid":"1706751","id":"PMC_1706751","title":"T cell receptor-independent CD2 signal transduction in FcR+ cells.","date":"1991","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1706751","citation_count":25,"is_preprint":false},{"pmid":"19586919","id":"PMC_19586919","title":"Inhibition and activation by CD244 depends on CD2 and phospholipase C-gamma1.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19586919","citation_count":25,"is_preprint":false},{"pmid":"22973059","id":"PMC_22973059","title":"Cd²⁺ block and permeation of CaV3.1 (α1G) T-type calcium channels: candidate mechanism for Cd²⁺ influx.","date":"2012","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22973059","citation_count":25,"is_preprint":false},{"pmid":"32398348","id":"PMC_32398348","title":"Phosphoproteomics of CD2 signaling reveals AMPK-dependent regulation of lytic granule polarization in cytotoxic T cells.","date":"2020","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/32398348","citation_count":25,"is_preprint":false},{"pmid":"9565369","id":"PMC_9565369","title":"Activation-induced NK cell death triggered by CD2 stimulation.","date":"1998","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9565369","citation_count":25,"is_preprint":false},{"pmid":"10510361","id":"PMC_10510361","title":"CD2 and CD3 associate independently with CD5 and differentially regulate signaling through CD5 in Jurkat T cells.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10510361","citation_count":25,"is_preprint":false},{"pmid":"11195047","id":"PMC_11195047","title":"CD2-associated protein and the kidney.","date":"2001","source":"Current opinion in nephrology and hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/11195047","citation_count":24,"is_preprint":false},{"pmid":"1384685","id":"PMC_1384685","title":"Expression of the CD2 molecule on human B lymphoid progenitors.","date":"1992","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1384685","citation_count":24,"is_preprint":false},{"pmid":"2895712","id":"PMC_2895712","title":"Immunoregulatory functions of paf-acether. II. Decrease of CD2 and CD3 antigen expression.","date":"1988","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2895712","citation_count":23,"is_preprint":false},{"pmid":"26584949","id":"PMC_26584949","title":"CD2-associated protein participates in podocyte apoptosis via PI3K/Akt signaling pathway.","date":"2015","source":"Journal of receptor and signal transduction research","url":"https://pubmed.ncbi.nlm.nih.gov/26584949","citation_count":22,"is_preprint":false},{"pmid":"18177421","id":"PMC_18177421","title":"CD2-associated protein is widely expressed and differentially regulated during embryonic development.","date":"2008","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/18177421","citation_count":22,"is_preprint":false},{"pmid":"23112830","id":"PMC_23112830","title":"CD2 promotes human natural killer cell membrane nanotube formation.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23112830","citation_count":22,"is_preprint":false},{"pmid":"2903216","id":"PMC_2903216","title":"Identification of CD2-/CD3+ T cells in fetal human tissue.","date":"1988","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2903216","citation_count":22,"is_preprint":false},{"pmid":"9727049","id":"PMC_9727049","title":"A p56lck-independent pathway of CD2 signaling involves Jun kinase.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9727049","citation_count":21,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45064,"output_tokens":9223,"usd":0.136768,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19480,"output_tokens":5979,"usd":0.123438,"stage2_stop_reason":"end_turn"},"total_usd":0.260206,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1987,\n      \"finding\": \"CD2 (T lymphocyte glycoprotein) binds the cell surface ligand LFA-3 (CD58) with high affinity, mediating adhesion of lymphoid cells.\",\n      \"method\": \"Purified CD2 inhibition of rosetting; cell adhesion assays with purified LFA-3\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct binding assay with purified proteins, replicated across multiple labs (PMIDs 2951597, 3102975, 3313052)\",\n      \"pmids\": [\"2951597\", \"3102975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1987,\n      \"finding\": \"LFA-3 (the ligand for CD2) is a phospholipid-linked (GPI-anchored) membrane protein whose extracellular domain shares significant homology with CD2, placing both in the immunoglobulin superfamily.\",\n      \"method\": \"cDNA cloning and transient expression in mouse cells; sequence analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cDNA cloning with functional expression, widely replicated\",\n      \"pmids\": [\"3313052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1987,\n      \"finding\": \"Binding of the natural CD2 ligand (T11TS/LFA-3) to CD2 on resting T cells induces reactivity to mitogenic anti-CD2 antibody stimuli, establishing CD2-ligand interaction as providing one signal required for alternative-pathway T cell activation.\",\n      \"method\": \"T cell stimulation assays with natural cell-surface ligand and monoclonal antibodies\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional cell stimulation assays with natural ligand, replicated across labs\",\n      \"pmids\": [\"3102975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1987,\n      \"finding\": \"Mutational analysis mapped the LFA-3 binding site of CD2 to the first extracellular domain, corresponding to immunoglobulin variable region hypervariable sequences; activating anti-CD2 antibodies bind overlapping epitopes in regions 1 and 3, supporting the model that they mimic LFA-3 binding.\",\n      \"method\": \"Systematic mutagenesis of CD2 followed by antibody binding and LFA-3 binding assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct mutagenesis with functional binding readout, single lab with comprehensive mapping\",\n      \"pmids\": [\"2444890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"CD2-mediated T cell activation requires phosphoinositide turnover that is linked to the CD3-Ti complex; CD3-Ti-negative Jurkat mutants cannot be activated through either CD3 or CD2 pathways, and this is rescued by TCR reconstitution, demonstrating interdependence of the two pathways.\",\n      \"method\": \"Jurkat mutant cell lines (CD3-Ti-negative); phosphoinositide turnover assays; Ca2+ mobilization; IL-2 gene induction; DNA transfection rescue\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined biochemical readouts and rescue experiment, multiple orthogonal endpoints\",\n      \"pmids\": [\"2901344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"The CD2 extracellular adhesion domain (LFA-3 binding) is functionally separable from its cytoplasmic signal transduction domain; CD2 mutants lacking functional cytoplasmic domain still enhance antigen-specific T cell responses by up to 400% when LFA-3 is present on the same APC, demonstrating that adhesion per se contributes to T cell activation.\",\n      \"method\": \"Transfection of CD2 cytoplasmic-domain truncation mutants into antigen-specific T cell hybridoma; antigen-specific proliferation assays with LFA-3-expressing APCs\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain deletion mutagenesis with functional antigen-specific readout, clean experimental design\",\n      \"pmids\": [\"2566919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"CD2 is physically associated with CD45 (a tyrosine phosphatase) on the surface of human T lymphocytes, providing a molecular basis for the co-mitogenic effect of anti-CD45 and anti-CD2 antibodies.\",\n      \"method\": \"Chemical crosslinking followed by co-immunoprecipitation\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single crosslinking/co-IP study, single lab, no functional dissection of the complex\",\n      \"pmids\": [\"1970422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Lateral mobility of GPI-anchored LFA-3 on supported lipid bilayers enhances CD2-mediated T cell adhesion strength by facilitating receptor accumulation and bond formation in the contact zone; mobile GPI-LFA-3 strengthens adhesion faster than immobile transmembrane-LFA-3 at low ligand densities.\",\n      \"method\": \"Reconstituted planar lipid bilayers with two LFA-3 isoforms; static and laminar-flow cell adhesion assays; fluorescence recovery after photobleaching (FRAP)\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted bilayer system with two receptor isoforms, multiple quantitative assays, clean experimental design\",\n      \"pmids\": [\"1717480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"CD2 adhesion function is constitutively active in non-activated T cells and is not detectably modulated by TCR stimulation, protein kinase C activation, or cAMP; in contrast, LFA-1 adhesion is minimal at rest and upregulated by TCR signaling, demonstrating complementary roles of CD2 and LFA-1 in initiating vs. sustaining cell-cell contact.\",\n      \"method\": \"Cell adhesion assays; pharmacological modulation (PKC activators, cAMP); flow cytometry\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional adhesion assays with pharmacological dissection, single lab\",\n      \"pmids\": [\"1672642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"CD2-mediated signal transduction in T lymphocytes requires the CD3 zeta cytoplasmic domain; expression of a CD8α/CD3ζ chimeric receptor in TCR-negative Jurkat cells restored Ca2+ mobilization, protein tyrosine kinase activation, and IL-2 secretion upon CD2 stimulation, demonstrating that CD3ζ is a necessary and sufficient TCR subunit for coupling CD2 to signaling.\",\n      \"method\": \"CD8α/CD3ζ chimeric receptor transfection into TCR-negative Jurkat; Ca2+ mobilization; protein tyrosine kinase assay; IL-2 secretion\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — chimeric receptor reconstitution with multiple signaling readouts, mechanistically definitive\",\n      \"pmids\": [\"1351920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"On NK cells, CD16 (FcγRIII) is functionally equivalent to the TCR for coupling CD2 to signaling; transfecting a transmembrane CD16 into TCR-negative Jurkat cells (which express endogenous CD3ζ) restores CD2 signaling; CD2 signaling further requires a wild-type CD3ζ subunit, establishing CD3ζ as the essential downstream effector of CD2-triggered signaling in both T and NK cells.\",\n      \"method\": \"CD16 cDNA transfection into TCR-negative Jurkat; wild-type vs. truncated CD3ζ T-T hybridomas; Ca2+ mobilization; IL-2 production\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with chimeric/mutant receptors, multiple cell lines, mechanistically rigorous\",\n      \"pmids\": [\"1346934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"CD48 is the counter-receptor for mouse CD2; identified by generating a CD2-Ig fusion protein to screen for binding partners on T cell lines; confirmed by protein microsequencing, anti-CD48 antibody blocking, and soluble CD48 inhibition; anti-CD48 antibody inhibited PHA responses and augmented anti-CD3 responses of splenic T cells.\",\n      \"method\": \"Chimeric mCD2-IgG1 fusion protein; mAb screening; protein microsequencing; soluble recombinant CD48 blocking assay; T cell proliferation assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical identification with multiple orthogonal methods including microsequencing and functional blocking\",\n      \"pmids\": [\"1383383\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"TCR-CD3 signaling rapidly increases CD2 avidity for CD58 (LFA-3); the carboxyl-terminal asparagine of the CD2 cytoplasmic domain is essential for this avidity regulation but not for CD2-mediated signaling; cell lines incapable of CD2 avidity regulation show marked deficiency in antigen-specific T cell responses.\",\n      \"method\": \"CD2 cytoplasmic domain point mutants transfected into T cell lines; CD58-binding avidity assay; antigen-specific proliferation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of cytoplasmic domain with functional avidity and antigen-response readouts, clean domain dissection\",\n      \"pmids\": [\"1353888\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"N-glycosylation at Asn65 in the CD2 extracellular domain is essential for CD2-CD58 binding; deglycosylated CD2 or Asn65→Gln65 mutant CD2 fails to bind CD58 or conformational anti-CD2 antibodies, indicating N-glycans stabilize the adhesion domain structure.\",\n      \"method\": \"Enzymatic deglycosylation; site-directed mutagenesis (Asn65→Gln); CD58-binding assays; electrospray ionization mass spectrometry characterization of glycoforms\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis plus deglycosylation with direct binding readout, mass spectrometry characterization\",\n      \"pmids\": [\"1385399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The CD2 cytoplasmic domain contains two structurally and functionally separable regions: one required for signal transduction (IL-2 production) and a distinct COOH-terminal 21-aa region required for TCR-induced avidity regulation for CD58; regulated avidity and signaling each independently contribute to optimal antigen-specific T cell responses.\",\n      \"method\": \"Series of CD2 cytoplasmic domain deletion/point mutants stably transfected in antigen-specific T cell hybridoma; IL-2 production assays; CD58-avidity assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic mutagenesis with multiple functional readouts, clean domain mapping\",\n      \"pmids\": [\"7901319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"TCR-initiated upregulation of CD2 avidity for CD58 requires both protein tyrosine kinases and protein kinase C activity; cAMP also upregulates CD2 avidity independently of PKC and PTK; all three stimuli require the COOH-terminal asparagine of CD2 cytoplasmic domain as a common structural element, distinguishing this regulatory mechanism from LFA-1 and CD8 avidity regulation.\",\n      \"method\": \"Pharmacological inhibitors of PTK and PKC; cAMP elevation; CD2 point mutants; rosetting and CD58-binding avidity assays in transfected T cell hybridomas\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological dissection combined with mutagenesis, single lab\",\n      \"pmids\": [\"7681075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CD2 associates with protein tyrosine kinases p56lck and p59fyn, and with CD3 zeta and epsilon chains, forming a multimolecular signaling complex in T lymphocytes; induction of T cell unresponsiveness (by CD3/TCR modulation) uncouples zeta and epsilon from CD2 while p56lck and p59fyn associations remain, correlating with loss of CD2-mediated proliferation.\",\n      \"method\": \"In vitro kinase assays on CD2 immunoprecipitates from Brij-58 T lymphocyte lysates; double indirect immunofluorescence with capping\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP/kinase assay with immunofluorescence confirmation, single lab, two complementary methods\",\n      \"pmids\": [\"8093441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"CD2 forms a signaling complex with CD3 zeta chain and the Src-family kinase p59fyn in T lymphocytes, identified by in vitro kinase assays on CD2 immunoprecipitates and confirmed by double indirect immunofluorescence capping in viable T lymphocytes.\",\n      \"method\": \"In vitro kinase assays; immunoprecipitation; double indirect immunofluorescence capping\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP/kinase assay plus imaging, single lab, two complementary methods\",\n      \"pmids\": [\"7912674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"A cytoplasmic protein CD2BP2 binds directly to two PPPGHR motifs in the CD2 cytoplasmic domain via a novel 17-aa GYF-containing proline-binding module distinct from SH3 and WW domains; over-expression of the CD2BP2 binding domain in Jurkat cells enhances IL-2 production upon CD2 crosslinking but not TCR crosslinking.\",\n      \"method\": \"Interaction trap cloning; mutagenesis; NMR structure of CD2BP2 binding domain; functional over-expression in Jurkat cells with IL-2 production assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structural analysis with mutagenesis and functional assay, multiple orthogonal methods\",\n      \"pmids\": [\"9843987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CD2BP1 (a cdc15-like adaptor protein, also called PSTPIP1) binds directly to the CD2 cytoplasmic sequence KGPPLPRPRV via its SH3 domain; upon ligand-induced CD2 clustering, CD2BP1 redistributes from cytosol to the membrane co-localizing with CD2 and downregulates CD2-stimulated adhesion, apparently by coupling PTP-PEST to CD2.\",\n      \"method\": \"Interaction trap cloning; direct SH3 domain binding assay; immunofluorescence co-localization; CD2 adhesion assays with CD2BP1 expression\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding assay, co-localization, and functional adhesion readout, multiple orthogonal methods\",\n      \"pmids\": [\"9857189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CD2 contains a p56lck-independent signaling pathway; CD2-mediated IL-2 production occurs via activation of Jun kinase (JNK) in cell lines lacking p56lck, with c-Jun/c-Fos binding to the AP-1 site driving IL-2 promoter activity, demonstrating mechanistic divergence between CD2 and TCR signaling.\",\n      \"method\": \"p56lck-deficient T cell lines; CD2 stimulation; JNK kinase assay; AP-1 transcription factor binding; IL-2 promoter activity\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinase assays and transcription factor assays in genetically defined cell lines, single lab\",\n      \"pmids\": [\"9727049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CD2 physically associates with CD5 in T lymphocytes independently of CD3; CD2 cross-linking leads to dephosphorylation of CD5 (in contrast to CD3 stimulation which phosphorylates CD5) correlated with enhanced SHP-1 phosphatase activity, identifying CD5 phosphorylation state as a CD2-regulated signaling node.\",\n      \"method\": \"Co-immunoprecipitation in CD3-deficient and CD2-deficient Jurkat cells; phosphotyrosine western blotting; SHP-1 phosphatase activity assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP in genetically defined cell lines plus enzyme activity assay, single lab\",\n      \"pmids\": [\"10510361\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"p59fyn is a critical upstream kinase in the CD2 signaling pathway; in fyn-/- mice expressing transgenic human CD2, CD2-induced Ca2+ mobilization, MAPK activation, and T cell proliferation are markedly reduced, while TCR-triggered proliferation is unaffected; CD2 pathway substrates of fyn include PLCγ1, Vav, PKCθ, Dok, FAK, and Pyk2.\",\n      \"method\": \"Human CD2 transgenic fyn-/- mice; T cell stimulation assays; Ca2+ flux; MAPK assays; substrate phosphorylation analysis; proliferation assays\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout mice with transgenic CD2, multiple orthogonal biochemical readouts, clean separation of CD2 vs. TCR pathways\",\n      \"pmids\": [\"11093170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CD2 and LFA-1 facilitate T cell activation additively; absence of both CD2-CD48 and LFA-1-ICAM-1 interactions in CD2-deficient mice shifts the antigen dose-response by ~100-fold; CD2 absence affects conjugate formation, TCR triggering, and Ca2+ flux at low antigen density.\",\n      \"method\": \"CD2-deficient mice crossed with TCR-transgenic mice; T cell-APC conjugate formation assay; TCR triggering assay; Ca2+ flux measurement; in vivo LCMV infection\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with transgenic TCR, multiple mechanistic readouts, in vitro and in vivo\",\n      \"pmids\": [\"10562314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"p62dok is a negative regulator of CD2 signaling; over-expression of p62dok in Jurkat cells inhibits CD2-mediated (but not CD3-mediated) Ca2+ increase, PLCγ1 activation, and ERK1/2 activation; CD2 (but not CD3) stimulation induces p62dok and RasGAP recruitment to the plasma membrane.\",\n      \"method\": \"Stable over-expression of p62dok in Jurkat cells; Ca2+ flux; PLCγ1 activation assay; ERK1/2 phosphorylation; membrane fractionation; NF-AT reporter assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function with multiple signaling readouts specifically dissecting CD2 vs. CD3 pathways, single lab\",\n      \"pmids\": [\"11254695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CD2AP directly binds filamentous actin (F-actin) through its COOH terminus, acting as a direct adapter between the actin cytoskeleton and membrane proteins such as nephrin and polycystin-2; disruption of the actin cytoskeleton disorganizes endogenous CD2AP distribution.\",\n      \"method\": \"F-actin coprecipitation assay with purified CD2AP fusion proteins; cytoskeletal fractionation by differential centrifugation; fluorescence co-localization in cultured cells; actin depolymerization experiments\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution (purified proteins), domain mapping, and cellular fractionation, multiple orthogonal methods\",\n      \"pmids\": [\"12217865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Alefacept (LFA-3/IgG1 fusion protein) mediates apoptosis of CD2+ T cells by bridging CD2 on T cells with CD16 (FcγRIII) on NK cells; signaling is transduced through CD16, not CD2; confirmed using IgG1 CH2 domain Fc mutants that ablate FcγR binding, and in human CD2-transgenic mice.\",\n      \"method\": \"Alefacept Fc-region amino acid substitution mutants; ERK phosphorylation; CD25 expression; granzyme B release; human CD2-transgenic mouse model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis of effector function with multiple functional readouts and in vivo mouse model, clean dissection of CD2 vs. CD16 signaling\",\n      \"pmids\": [\"11970990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Nanoscale increases in intermembrane spacing (from 12.8 nm with CD48-WT to 14.7–15.6 nm with extended CD48 chimeras) reduce CD2-mediated adhesion efficiency 10-fold and reorganize the immunological synapse, sequestering TCR away from its ligand.\",\n      \"method\": \"CD48 chimeras with additional Ig domains; electron tomography of contact areas; confocal imaging of immunological synapses; quantitative adhesion assays with planar bilayers\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — electron tomography structural measurements combined with functional adhesion and synapse organization assays\",\n      \"pmids\": [\"18826951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CD2AP is required for cytokinesis in HeLa cells; it localizes to the midbody during telophase (as a membrane-associated, not microtubule-associated, protein), interacts with the cleavage furrow protein anillin (by yeast two-hybrid), and siRNA-mediated knockdown of CD2AP causes cell multinucleation/failure of cell separation; CD2AP is phosphorylated during mitosis.\",\n      \"method\": \"Immunofluorescence localization; SH3 domain overexpression; siRNA knockdown; yeast two-hybrid; phosphorylation analysis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function (siRNA) with specific cytokinesis phenotype, yeast two-hybrid interaction, localization data, multiple methods\",\n      \"pmids\": [\"15800069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CD2 concentrates in a large T cell invagination at the center of the T cell-APC interface within 1 minute of contact formation; dissolution of this invagination and CD2 engagement are required for effective proximal TCR signaling; CD2 is the most prominently internalized receptor in this structure.\",\n      \"method\": \"Live fluorescence microscopy of T cell-APC conjugates; antibody blocking; quantitative receptor tracking\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live imaging with functional signaling readout, single lab\",\n      \"pmids\": [\"16982875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"T cell activation causes a 1.5-fold increase in cell-surface CD2 numbers, a 2.5-fold increase in 2D affinity for CD58, and immobilization of ligated CD2 at the contact zone (reduced lateral mobility); these combined changes substantially enhance CD2 avidity and strengthen T cell-APC adhesion.\",\n      \"method\": \"Quantitative fluorescence imaging of CD2 numbers; 2D affinity measurement; FRAP of CD2 on resting vs. activated T cells\",\n      \"journal\": \"ACS chemical biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative biophysical measurements, single lab, multiple parameters\",\n      \"pmids\": [\"17168569\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CD2-CD58 interaction synergizes with TCR to activate PLC-γ1 at the immunological synapse; blocking CD2-CD58 interaction reduces PLCγ1 recruitment to the IS and impairs phosphorylation of PLCγ1 at regulatory Tyr783, demonstrating that CD2 costimulation enhances TCR-induced calcium signaling through PLCγ1.\",\n      \"method\": \"Anti-CD58 antibody blocking; single-cell Ca2+ imaging; PLCγ1 immunofluorescence at IS; phospho-PLCγ1 (Tyr783) western blot\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — blocking experiment with multiple downstream signaling readouts, single lab\",\n      \"pmids\": [\"17220479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CD2 ligation by CD58 (in the absence of TCR activation) induces signaling through actin-dependent coalescence of TCR-ζ, Lck, and LAT into plasma membrane microdomains; when TCR and CD2 are co-activated, they initially co-localize then spatially segregate into separate zones, potentially enabling synergistic signaling.\",\n      \"method\": \"Jurkat T cells on planar lipid bilayers (CD58 only, without TCR ligand); single-molecule tracking; live TIRF microscopy; co-localization analysis\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single-molecule live imaging with a defined reconstituted system, multiple signaling molecules tracked, mechanistically informative\",\n      \"pmids\": [\"19398758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CD2 acts as a master adaptor linking Lck and CD48 to the TCR/CD3 complex during T cell activation; CD48 (GPI-anchored) is recruited to the immobilized TCR/CD3 complex in a CD2-dependent manner, and CD48 in turn recruits LAT to the TCR complex, establishing a hierarchical CD2→CD48→LAT signaling relay.\",\n      \"method\": \"Co-immunoprecipitation of TCR/CD3 complex with CD2, CD48, LAT, and Lck; T cell IL-2 production assays; knockdown experiments; CD2- and CD48-deficient cell analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with defined order of epistasis, single lab\",\n      \"pmids\": [\"19494291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CD2-CD58/48 receptor-ligand interaction is required for membrane nanotube formation by human NK cells; stable CD2 expression in CD2-negative NK cell line YTS enables nanotube formation and improves cytotoxic function; CD2 localizes to nanotube tips; blocking CD2 receptor-ligand interactions prevents nanotube formation.\",\n      \"method\": \"Stable CD2 transfection into CD2-negative YTS NK cells; quantitative live-cell fluorescence microscopy; blocking antibodies; cytotoxicity assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function and blocking experiments with quantitative live imaging and functional cytotoxicity readout, single lab\",\n      \"pmids\": [\"23112830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CD2 localizes to the outer edge of the mature immunological synapse (the 'CD2 corolla'), where it captures engaged co-stimulatory receptors (CD28, ICOS, CD226, SLAM-F1) and amplifies active phosphorylated SFK, LAT, and PLC-γ signaling by 77% compared to central CD2; corolla formation depends on CD2 copy number and specific cytoplasmic tail motifs; PD-1 invades the corolla and buffers CD2-mediated signaling amplification.\",\n      \"method\": \"Super-resolution imaging and confocal microscopy of IS with primary human T cells and artificial APCs; CD2 copy number manipulation; cytoplasmic tail truncation mutants; pSFK/LAT/PLCγ quantification; PD-1 co-engagement experiments\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple imaging modalities, mutagenesis of cytoplasmic tail, quantitative signaling readouts, and mechanistic intervention experiments in primary cells\",\n      \"pmids\": [\"32929275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CD2 costimulation drives AMPK-dependent polarization of lytic granules toward the MTOC in CD8+ CTLs; phosphoproteomics revealed 616 CD2-regulated phosphorylation events including AMPK pathway activation; AMPK enriched on lysosomes adjacent to granules drives this polarization.\",\n      \"method\": \"Phosphoproteomics of CD2-stimulated primary human CD8+ T cells; AMPK activity assays; lytic granule polarization imaging; lysosome-granule proximity analysis; functional cytotoxicity assays\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphoproteomics with functional validation of AMPK-granule axis in primary cells, multiple methods\",\n      \"pmids\": [\"32398348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CD2-CD48 cis interactions (within the same T cell membrane) are required for T cell activation; CD48 on APCs is dispensable for T cell activation (except during cytotoxicity), while T cell-intrinsic CD48 is necessary; FRET confirmed CD2-CD48 cis interactions in non-immune cells; mass spectrometry of CD2 knock-in T cells revealed that CD2 interacts with TCR complex components and Lck, correlating CD2 function with its association with the TCR signalosome.\",\n      \"method\": \"New CD2 and CD48 knockout mouse strains; FRET in non-immune cells; mass spectrometry of CD2 tag knock-in T cells; TCR signaling (protein tyrosine phosphorylation) assays; cytotoxicity assays\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — new genetic knockouts with FRET demonstration of cis interactions, mass spectrometry interactome, multiple functional readouts, rigorous study design\",\n      \"pmids\": [\"35930657\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CD2 is a T and NK cell surface glycoprotein that functions as both an adhesion molecule and a signaling co-receptor: its extracellular domain binds LFA-3/CD58 (in humans) or CD48 (in mice) in trans on APCs and also in cis on the same T cell, with cis CD2-CD48 interactions being required for TCR signaling; its cytoplasmic domain contains distinct regions for signal transduction (requiring CD3ζ and p59fyn) and for regulated avidity (requiring the COOH-terminal asparagine), and engages adaptor proteins CD2BP1 (via proline-rich motifs/SH3) and CD2BP2 (via a GYF motif); upon ligand engagement CD2 recruits Lck, CD3ζ/ε, and p59fyn into a signaling complex, activates PLCγ1, JNK, and AMPK pathways, localizes to the outer CD2 corolla of the immunological synapse to amplify TCR-proximal signaling by ~77%, and drives lytic granule polarization toward the MTOC in cytotoxic T cells.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CD2 is a T and NK cell surface immunoglobulin-superfamily glycoprotein that functions both as an adhesion molecule and as a costimulatory amplifier of antigen-receptor signaling [#0, #5, #23]. Its membrane-distal extracellular domain binds the GPI-anchored counter-receptor LFA-3/CD58 in humans and CD48 in mice through a hypervariable-like region of its first Ig domain, an interaction that requires N-glycosylation at Asn65 to maintain the binding-competent fold [#0, #1, #3, #11, #13]. This adhesion is constitutively active at rest and complements the inducible LFA-1 system; TCR engagement subsequently increases CD2 surface number, 2D affinity, and immobilization at the contact zone to strengthen conjugate formation, a regulated avidity that depends on the COOH-terminal asparagine of the cytoplasmic tail and is mechanistically separable from CD2's signaling output [#5, #8, #12, #14, #30]. The cytoplasmic domain couples ligand engagement to the TCR signalosome: CD2 associates with CD3\\u03b6/\\u03b5 and the Src-family kinases p56lck and p59fyn, and CD3\\u03b6 is the essential downstream subunit transducing CD2 signals in both T and NK cells, with p59fyn acting as the critical upstream kinase phosphorylating PLC\\u03b31, Vav, and other substrates [#9, #10, #16, #22]. Through this complex CD2 synergizes with the TCR to drive PLC\\u03b31 activation, calcium flux, and IL-2 production, and recent work places CD2-CD48 cis interactions on the same T cell membrane\\u2014rather than trans engagement of APC ligand\\u2014as the requirement for activation [#31, #33, #37]. The tail also engages dedicated adaptors: CD2BP2 binds PPPGHR motifs via a GYF module to enhance CD2-specific IL-2 output, while CD2BP1/PSTPIP1 binds via its SH3 domain and downregulates adhesion by coupling PTP-PEST to clustered CD2 [#18, #19]. Spatially, CD2 concentrates at the immunological synapse, forming an outer 'CD2 corolla' that captures costimulatory receptors and amplifies proximal SFK/LAT/PLC\\u03b3 signaling, and CD2 costimulation drives AMPK-dependent polarization of lytic granules toward the MTOC in cytotoxic T cells [#35, #36]. (Findings concerning CD2AP\\u2014actin binding, nephrin/polycystin linkage, and cytokinesis [#25, #28]\\u2014describe a distinct protein and are not part of CD2 receptor biology.)\",\n  \"teleology\": [\n    {\n      \"year\": 1987,\n      \"claim\": \"Establishing that CD2 is a high-affinity adhesion receptor for LFA-3/CD58 defined its founding molecular function and placed both partners in the Ig superfamily.\",\n      \"evidence\": \"Purified-protein binding and rosetting inhibition assays; cDNA cloning and sequence analysis of LFA-3\",\n      \"pmids\": [\"2951597\", \"3102975\", \"3313052\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not localize the binding interface on CD2\", \"Did not establish whether adhesion contributes to signaling\"]\n    },\n    {\n      \"year\": 1987,\n      \"claim\": \"Mapping the LFA-3 site to the first Ig domain and showing natural ligand delivers an activation signal connected adhesion structure to function and to the 'alternative pathway' of T cell activation.\",\n      \"evidence\": \"Systematic CD2 mutagenesis with binding readouts; T cell stimulation with natural ligand and activating antibodies\",\n      \"pmids\": [\"2444890\", \"3102975\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the cytoplasmic signaling machinery\", \"Did not separate adhesion from signal transduction\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Demonstrating that CD2 activation requires an intact CD3-Ti complex established interdependence between the CD2 and TCR pathways rather than fully independent signaling.\",\n      \"evidence\": \"CD3-Ti-negative Jurkat mutants with phosphoinositide/Ca2+/IL-2 readouts and TCR reconstitution rescue\",\n      \"pmids\": [\"2901344\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify which TCR subunit is the coupling element\", \"Did not address adhesion-only contributions\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Showing that cytoplasmic-tailless CD2 still enhances antigen-specific responses dissected adhesion per se from signal transduction as separable contributors to activation.\",\n      \"evidence\": \"CD2 cytoplasmic truncation mutants in antigen-specific hybridomas with LFA-3+ APCs\",\n      \"pmids\": [\"2566919\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the signaling motifs in the retained vs. deleted tail\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Biophysical reconstitution showed ligand lateral mobility strengthens CD2 adhesion and that CD2 adhesion is constitutively active, distinguishing it from inducible LFA-1.\",\n      \"evidence\": \"Planar bilayers with GPI vs. transmembrane LFA-3, FRAP, flow adhesion assays; pharmacological modulation of adhesion\",\n      \"pmids\": [\"1717480\", \"1672642\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not connect adhesion strength to downstream signaling magnitude in primary cells\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Chimeric-receptor reconstitution identified CD3\\u03b6 as the necessary and sufficient subunit coupling CD2 to signaling in both T and NK cells, resolving the coupling element left open in 1988.\",\n      \"evidence\": \"CD8\\u03b1/CD3\\u03b6 and CD16 chimeras in TCR-negative Jurkat with Ca2+, PTK, and IL-2 readouts; wild-type vs. truncated CD3\\u03b6\",\n      \"pmids\": [\"1351920\", \"1346934\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the physical linkage between CD2 tail and CD3\\u03b6\", \"Did not enumerate the kinases recruited\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Identifying CD48 as the mouse counter-receptor and Asn65/N-glycan as essential for ligand binding completed the ligand map and defined a glycan-dependent adhesion fold.\",\n      \"evidence\": \"CD2-Ig fusion screening with microsequencing and blocking; deglycosylation and Asn65\\u2192Gln mutagenesis with binding/MS\",\n      \"pmids\": [\"1383383\", \"1385399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address cis vs. trans engagement of CD48\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Defining TCR-induced avidity regulation and pinning it to the COOH-terminal asparagine revealed a dynamic adhesion-tuning function distinct from CD2 signaling output.\",\n      \"evidence\": \"CD2 cytoplasmic point/deletion mutants in T cell lines with CD58-avidity and antigen-proliferation assays\",\n      \"pmids\": [\"1353888\", \"7901319\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the trans-acting regulator binding the C-terminal asparagine region\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Co-IP/kinase work assembled the CD2 signaling complex (p56lck, p59fyn, CD3\\u03b6/\\u03b5) and linked avidity upregulation to PTK/PKC/cAMP inputs converging on the C-terminal asparagine.\",\n      \"evidence\": \"In vitro kinase assays on CD2 immunoprecipitates, immunofluorescence capping; pharmacological PTK/PKC/cAMP dissection with mutants\",\n      \"pmids\": [\"8093441\", \"7912674\", \"7681075\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-IP associations not reconstituted to establish directness\", \"Single-lab kinase assays\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Cloning CD2BP2 and CD2BP1/PSTPIP1 identified dedicated tail adaptors with opposing effects on CD2 signaling vs. adhesion, defining a proline-motif-based regulatory module.\",\n      \"evidence\": \"Interaction trap cloning, NMR of CD2BP2 GYF domain, SH3 binding assays, co-localization, IL-2 and adhesion readouts\",\n      \"pmids\": [\"9843987\", \"9857189\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish how adaptor engagement is temporally regulated during synapse formation\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating a p56lck-independent JNK/AP-1 arm of CD2 signaling showed mechanistic divergence between CD2 and TCR signaling beyond shared components.\",\n      \"evidence\": \"CD2 stimulation in p56lck-deficient lines with JNK assay, AP-1 binding, and IL-2 promoter reporter\",\n      \"pmids\": [\"9727049\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not identify the kinase relay upstream of JNK in the absence of Lck\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identifying CD2-induced CD5 dephosphorylation and SHP-1 activation, and later p62dok recruitment, exposed negative-regulatory nodes specific to CD2 signaling.\",\n      \"evidence\": \"Reciprocal co-IP in CD3/CD2-deficient Jurkat with SHP-1 activity; p62dok overexpression with Ca2+/PLC\\u03b31/ERK readouts\",\n      \"pmids\": [\"10510361\", \"11254695\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not establish physiological roles in primary T cells\", \"Single-lab gain/loss studies\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Genetic knockout and transgenic models established p59fyn as the critical CD2 kinase and quantified CD2's additive contribution with LFA-1 to lowering the antigen activation threshold.\",\n      \"evidence\": \"Human CD2-transgenic fyn-/- mice and CD2-deficient TCR-transgenic mice with Ca2+, MAPK, conjugate, and in vivo LCMV readouts\",\n      \"pmids\": [\"11093170\", \"10562314\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve spatial organization of CD2 signaling at the synapse\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showing that nanoscale intermembrane spacing controls CD2 adhesion and synapse organization linked CD2 dimensions directly to TCR triggering geometry.\",\n      \"evidence\": \"Extended CD48 chimeras with electron tomography, confocal synapse imaging, and bilayer adhesion assays\",\n      \"pmids\": [\"18826951\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map the molecular sensors that read intermembrane distance\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Live imaging revealed CD2 concentration in an early central invagination and quantified the activation-induced increases in CD2 number, 2D affinity, and immobilization underlying avidity enhancement.\",\n      \"evidence\": \"Live microscopy of T cell-APC conjugates; quantitative imaging, 2D affinity measurement, and FRAP\",\n      \"pmids\": [\"16982875\", \"17168569\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab imaging studies\", \"Did not directly link invagination dynamics to defined signaling molecules\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Single-molecule and reconstitution studies placed CD2 as an actin-dependent organizer that coalesces TCR\\u03b6/Lck/LAT microdomains and relays CD2\\u2192CD48\\u2192LAT to the TCR signalosome.\",\n      \"evidence\": \"Jurkat on CD58-only bilayers with single-molecule TIRF tracking; co-IP epistasis of CD2/CD48/LAT/Lck with IL-2 assays\",\n      \"pmids\": [\"19398758\", \"19494291\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-IP epistasis not reconstituted with purified components\", \"Did not resolve cis vs. trans CD48 source\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"CD2-CD48/CD58 interaction was shown to be required for NK cell membrane nanotube formation and cytotoxic function, extending CD2's role to NK effector architecture.\",\n      \"evidence\": \"Stable CD2 expression in CD2-negative YTS cells, blocking antibodies, live imaging, cytotoxicity assays\",\n      \"pmids\": [\"23112830\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"Did not define the signaling pathway driving nanotube formation\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Super-resolution imaging and phosphoproteomics defined the outer 'CD2 corolla' that captures costimulatory receptors to amplify proximal signaling and a CD2-driven AMPK axis polarizing lytic granules toward the MTOC.\",\n      \"evidence\": \"Super-resolution/confocal IS imaging with copy-number and tail-truncation manipulation; phosphoproteomics with AMPK and granule-polarization functional validation in primary human T cells\",\n      \"pmids\": [\"32929275\", \"32398348\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not fully define the tail motifs controlling corolla formation at residue level\", \"Mechanism of AMPK enrichment on granule-adjacent lysosomes not resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"New knockouts, FRET, and CD2 interactome mass spectrometry redefined the activation requirement as CD2-CD48 cis interactions on the T cell, with CD2 physically associating with the TCR complex and Lck.\",\n      \"evidence\": \"CD2 and CD48 knockout mouse strains, FRET in non-immune cells, mass spectrometry of CD2 knock-in T cells, TCR phosphorylation and cytotoxicity assays\",\n      \"pmids\": [\"35930657\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not structurally resolve the cis CD2-CD48 complex\", \"Did not reconcile cis requirement with prior trans-adhesion models mechanistically\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CD2 cytoplasmic-tail motifs, cis CD48 engagement, and corolla positioning are integrated into a single physical mechanism that couples adhesion geometry to TCR-proximal signaling amplification remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of the assembled CD2 signaling complex with CD3\\u03b6/Lck\", \"Quantitative rules linking corolla composition to signal amplification undefined\", \"Reconciliation of cis vs. trans CD2-CD48 engagement in vivo incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 5, 7, 8, 23]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 9, 10, 22, 31]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [33, 37]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [12, 14, 35]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 16, 19, 29, 32, 35]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 9, 22, 23, 35, 36]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 22, 31, 33]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [0, 23, 27]}\n    ],\n    \"complexes\": [\"TCR/CD3-CD2 signaling complex\", \"CD2 corolla\"],\n    \"partners\": [\"CD58\", \"CD48\", \"CD3Z\", \"FYN\", \"LCK\", \"CD2BP2\", \"PSTPIP1\", \"CD5\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":8,"faith_total":8,"faith_pct":100.0}}